Testing effectiveness (Phase 2)Ended earlyNCT03911076What this trial is testingPhase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSILWho this might be right forASC-USASC-HLSIL PapiVax Biotech, Inc. 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303751What this trial is testingStudy Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPVWho this might be right forHPVHigh-risk HPV (Any Strain)Human Papillomavirus (HPV) Infections Institut d'Investigació Biomèdica de Bellvitge 80
Large-scale testing (Phase 3)Ended earlyNCT02329171What this trial is testingImiquimod Treatment of CIN LesionsWho this might be right forCervical Intraepithelial Neoplasia Maastricht University Medical Center 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07668960What this trial is testingEvaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)Who this might be right forHigh-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection Shanghai Mianyi Biopharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07431502What this trial is testingTrial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial LesionsWho this might be right forPatients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vulvar SitePatients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vaginal SitePatients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Penile Site+2 more Gustave Roussy, Cancer Campus, Grand Paris
Not applicableStudy completedNCT00873288What this trial is testingActivating Collaborative CIS Support Via Targeted Provider MailingWho this might be right forPrecancerous Condition Northwestern University 254
Early research (Phase 1)Study completedNCT03239223What this trial is testingStudy of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) InfectionWho this might be right forHSILHSIL of CervixHigh-Grade Squamous Intraepithelial Lesions+7 more Antiva Biosciences 16
Not applicableUnknownNCT01385436What this trial is testingDistribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From CroatiaWho this might be right forCervical Cancer University Hospital for Infectious Diseases, Croatia 400
Not applicableUnknownNCT06333743What this trial is testingLaser Ablation in the Treatment of High-grade Cervical LesionsWho this might be right forHigh-Grade Squamous Intraepithelial Lesions Peking Union Medical College Hospital 308
Testing effectiveness (Phase 2)UnknownNCT02576561What this trial is testingSafety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSILWho this might be right forHuman PapillomavirusHigh-Grade Squamous Intraepithelial Lesions THEVAX Genetics Vaccine 10
Not applicableStudy completedNCT06325592What this trial is testingAssociation Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSILWho this might be right forHigh-Grade Squamous Intraepithelial Lesions Sichuan Cancer Hospital and Research Institute 826
Testing effectiveness (Phase 2)UnknownNCT03549273What this trial is testingEvaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial LesionsWho this might be right forCarcinomaNeoplasia; Intraepithelial, CervixGlandular Neoplasms+2 more Catalysis SL 62
Not applicableUnknownNCT02937155What this trial is testingIn the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?Who this might be right forHSIL, High-Grade Squamous Intraepithelial LesionsAdenocarcinoma in SituEarly Cervical Cancer Sunnybrook Health Sciences Centre 100
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT07572396What this trial is testingPhase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic AbnormalitiesWho this might be right forHigh-risk HPV (Any Strain)LSIL, Low Grade Squamous Intraepithelial LesionASC-US+3 more Amplexd Therapeutics, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT02864147What this trial is testingTreatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)Who this might be right forCervical Intraepithelial NeoplasiaCervical Dysplasia Yale University 134
Testing effectiveness (Phase 2)Study completedNCT01928225What this trial is testingRandomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSILWho this might be right forCervical High Grade Squamous Intraepithelial Lesion University of Witwatersrand, South Africa 180
Large-scale testing (Phase 3)Study completedNCT03721978What this trial is testingREVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)Who this might be right forCervical DysplasiaCervical High Grade Squamous Intraepithelial LesionHSIL Inovio Pharmaceuticals 203
Not applicableLooking for participantsNCT04057924What this trial is testingTherapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICINWho this might be right forHPV InfectionCervical Cancer University Hospital, Bordeaux 200
Testing effectiveness (Phase 2)Study completedNCT00703196What this trial is testingFolic Acid Clinical Trial for the Prevention of Cervical CancerWho this might be right forCervical CancerPrecancerous Condition University of Alabama at Birmingham 368